Articles Tagged With:
-
Take the Right Steps to Speed Resolution of Malpractice Litigation
Steps taken in the early phase of malpractice litigation can significantly affect the length of the case, with the right moves resulting in a faster, cheaper resolution. On the other hand, missteps and oversights can draw out the case, costing more in legal fees and more on the eventual settlement. -
CGRP Antagonists: What Is Their Role in Headache Therapy?
Migraine is a highly prevalent and debilitating condition that causes significant impairment in quality of life. Preventive therapy for migraine is indicated when migraine attacks interfere with quality of life or are frequent and debilitating. The ability to prevent migraine with pharmacologic therapy has long been a goal of both patients and their physicians. The ideal preventive (prophylactic) migraine treatment should be effective, safe, and well tolerated, with few or no contraindications, few or no drug interactions, safety in pregnancy and breastfeeding, and dosed in a manner to ease adherence.
-
Patient Pool Eligible for Lung Cancer Screening Expands Under Amended Criteria
CMS lowers age, smoking history thresholds.
-
More Research Needed on How Marijuana Affects Human Brain
American Heart Association conducts thorough literature review on the subject.
-
Midline Catheters May Be a Safer Option than Peripherally Inserted Central Catheters
Whenever possible, use of midline catheters over peripherally inserted central catheters could be safer for patients.
-
Patients’ Goals During Long-Term Acute Care Hospital Stays
After a long-term acute care hospital stay, most patients will achieve goals of ventilator liberation, eating, drinking, and speaking, but many will not achieve independence in walking, grooming, toileting, or returning home.
-
Enteral Nutrition During Prone Positioning in Critically Ill Patients
The author reviews the use of enteral nutrition in critically ill patients during prone positioning.
-
Urgent Need for ‘Universal’ Vaccines for SARS-CoV-2
There is an emerging consensus in the scientific community that is two-fold: COVID-19 is not going away anytime soon, and continuous vaccine boosters eventually could yield diminishing returns. What is needed are new, second-generation vaccines that confer broader immunity against both circulating variants and mutations yet to arise.
-
APIC Sets New Strategic Priorities Amid COVID-19
Like other healthcare workers, infection preventionists have been overwhelmed in the churning waves of the SARS-CoV-2 pandemic. An unpublished survey conducted by the Association for Professionals in Infection Control and Epidemiology and The Ohio State University School of Nursing revealed a “startling” level of stress and burnout.
-
Omicron ‘Milder’ Infection View Skewed by Prior Immunity
The COVID-19 omicron variant has been widely observed to cause “milder” disease, but this appears largely to be an illusion caused by the level of immunity via prior infection or vaccination that now exists in the human population.